Global Blood Plasma Products

Blood Plasma Products Comprehensive Study by Application (Immunology, Oncology, Pulmonology, Rheumatology, Transplant, Neurology, Hematology), Components (Immunoglobulin, Albumin, Hyperimmune Globulin, Coagulation, Other Plasma Fractionation Products), Mode of Delivery (Infusion Solutions, Gels, Sprays, Biomedical Sealants) Players and Region - Global Market Outlook to 2030

Blood Plasma Products Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Blood Plasma Products
Blood plasma is a liquid component that carries cells and proteins throughout the body. It is mostly water and contain dissolve proteins, glucose, oxygen, hormones, electrolytes, etc. It protect the body from infection and other blood disorder and also balance the electrolyte concentration. Blood plasma products used in several therapeutic treatments. The blood plasma products are used in hospitals, clinics and by research firms. Immunoglobulins is a component that is present in blood plasma which is further segmented into intravenous, subcutaneous and normal immunoglobulins.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Blood Plasma Products market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

ADMA Biologics, Inc. (United States), Cerus Corporation (United States), China Biologic Products, Inc. (China), CSL Limited (Australia), Biotest (Germany), Intas Pharmaceuticals Limited (India), Kedrion (Italy), LFB S.A. (France), Octapharma AG (Switzerland) and PrIME Biologics Pte Ltd. (Singapore) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Shanghai RAAS Blood Products Co., Ltd (China), Sanquin (Netherlands) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Blood Plasma Products market by , Application (Immunology, Oncology, Pulmonology, Rheumatology, Transplant, Neurology and Hematology) and Region.



On the basis of geography, the market of Blood Plasma Products has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Components, the sub-segment i.e. Immunoglobulin will boost the Blood Plasma Products market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Mode of Delivery, the sub-segment i.e. Infusion Solutions will boost the Blood Plasma Products market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Awareness about Blood and Plasma Donation and Introduction of New and Specialized Products

Market Growth Drivers:
Increase in Prevalence of Life-Threatening Disorders like Hemophilia and Increasing Usage in Plasma-Derived Medical Products

Challenges:
Post-Operative Risks Associated with Plasma Replacement Therapy

Restraints:
High Cost of Plasma Derivative-Based Therapy

Opportunities:
High Potential in Untapped Markets in the Emerging Economies

Market Leaders and their expansionary development strategies
In February 2021, Kamada Ltd., a plasma-derived biopharmaceutical company, announced that it has entered into an agreement for the acquisition of the plasma collection center and certain related rights and assets from the privately-held Blood and Plasma Research, Inc (B&PR) of Beaumont, TX, USA. B&PR’s collection facility primarily specializes in the collection of hyper-immune plasma used for the Anti-D immunoglobulin, which is manufactured by Kamada and distributed in international markets. B&PR’s plasma collection center is one of the few FDA-licensed centers in the U.S. providing the raw materials required for this product.
In May 2023, PlasmaGen Biosciences, a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, recently celebrated the official opening of the company's new manufacturing plant for blood plasma-derived protein therapeutics in Kolar, Bengaluru.
USFDA and Centre for biologics evaluation and research (CBER): The Clinical Laboratory Improvement Amendments (CLIA) of 1988 21 CFR Code of Federal Regulations, 606: cGMP for blood and blood components. and Regulation in Europe: Blood and blood products regulation is described in blood directive 2002/98/EC of European Parliament and council on setting “standards of safety and quality for the collection, processing, testing, storage and distribution of human blood and blood components “and directive 2005/62/EC which specified “community standard and specification relating to a quality system for blood establishment”.

Key Target Audience
Manufacturers of Blood Plasma Product, Suppliers of Blood Plasma Product, Wholesalers, Distributers and Retailers of Blood Plasma Product, Healthcare Industry, Research Firms and Governmental Bodies

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Immunology
  • Oncology
  • Pulmonology
  • Rheumatology
  • Transplant
  • Neurology
  • Hematology
By Components
  • Immunoglobulin
  • Albumin
  • Hyperimmune Globulin
  • Coagulation
  • Other Plasma Fractionation Products

By Mode of Delivery
  • Infusion Solutions
  • Gels
  • Sprays
  • Biomedical Sealants

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Prevalence of Life-Threatening Disorders like Hemophilia
      • 3.2.2. Increasing Usage in Plasma-Derived Medical Products
    • 3.3. Market Challenges
      • 3.3.1. Post-Operative Risks Associated with Plasma Replacement Therapy
    • 3.4. Market Trends
      • 3.4.1. Increasing Awareness about Blood and Plasma Donation
      • 3.4.2. Introduction of New and Specialized Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Plasma Products, by Application, Components, Mode of Delivery and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Blood Plasma Products (Value)
      • 5.2.1. Global Blood Plasma Products by: Application (Value)
        • 5.2.1.1. Immunology
        • 5.2.1.2. Oncology
        • 5.2.1.3. Pulmonology
        • 5.2.1.4. Rheumatology
        • 5.2.1.5. Transplant
        • 5.2.1.6. Neurology
        • 5.2.1.7. Hematology
      • 5.2.2. Global Blood Plasma Products by: Components (Value)
        • 5.2.2.1. Immunoglobulin
        • 5.2.2.2. Albumin
        • 5.2.2.3. Hyperimmune Globulin
        • 5.2.2.4. Coagulation
        • 5.2.2.5. Other Plasma Fractionation Products
      • 5.2.3. Global Blood Plasma Products by: Mode of Delivery (Value)
        • 5.2.3.1. Infusion Solutions
        • 5.2.3.2. Gels
        • 5.2.3.3. Sprays
        • 5.2.3.4. Biomedical Sealants
      • 5.2.4. Global Blood Plasma Products Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Blood Plasma Products (Volume)
      • 5.3.1. Global Blood Plasma Products by: Application (Volume)
        • 5.3.1.1. Immunology
        • 5.3.1.2. Oncology
        • 5.3.1.3. Pulmonology
        • 5.3.1.4. Rheumatology
        • 5.3.1.5. Transplant
        • 5.3.1.6. Neurology
        • 5.3.1.7. Hematology
      • 5.3.2. Global Blood Plasma Products by: Components (Volume)
        • 5.3.2.1. Immunoglobulin
        • 5.3.2.2. Albumin
        • 5.3.2.3. Hyperimmune Globulin
        • 5.3.2.4. Coagulation
        • 5.3.2.5. Other Plasma Fractionation Products
      • 5.3.3. Global Blood Plasma Products by: Mode of Delivery (Volume)
        • 5.3.3.1. Infusion Solutions
        • 5.3.3.2. Gels
        • 5.3.3.3. Sprays
        • 5.3.3.4. Biomedical Sealants
      • 5.3.4. Global Blood Plasma Products Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Blood Plasma Products (Price)
  • 6. Blood Plasma Products: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. ADMA Biologics, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cerus Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. China Biologic Products, Inc. (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. CSL Limited (Australia)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Biotest (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Intas Pharmaceuticals Limited (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Kedrion (Italy)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. LFB S.A. (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Octapharma AG (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PrIME Biologics Pte Ltd. (Singapore)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Blood Plasma Products Sale, by Application, Components, Mode of Delivery and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Blood Plasma Products (Value)
      • 7.2.1. Global Blood Plasma Products by: Application (Value)
        • 7.2.1.1. Immunology
        • 7.2.1.2. Oncology
        • 7.2.1.3. Pulmonology
        • 7.2.1.4. Rheumatology
        • 7.2.1.5. Transplant
        • 7.2.1.6. Neurology
        • 7.2.1.7. Hematology
      • 7.2.2. Global Blood Plasma Products by: Components (Value)
        • 7.2.2.1. Immunoglobulin
        • 7.2.2.2. Albumin
        • 7.2.2.3. Hyperimmune Globulin
        • 7.2.2.4. Coagulation
        • 7.2.2.5. Other Plasma Fractionation Products
      • 7.2.3. Global Blood Plasma Products by: Mode of Delivery (Value)
        • 7.2.3.1. Infusion Solutions
        • 7.2.3.2. Gels
        • 7.2.3.3. Sprays
        • 7.2.3.4. Biomedical Sealants
      • 7.2.4. Global Blood Plasma Products Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Blood Plasma Products (Volume)
      • 7.3.1. Global Blood Plasma Products by: Application (Volume)
        • 7.3.1.1. Immunology
        • 7.3.1.2. Oncology
        • 7.3.1.3. Pulmonology
        • 7.3.1.4. Rheumatology
        • 7.3.1.5. Transplant
        • 7.3.1.6. Neurology
        • 7.3.1.7. Hematology
      • 7.3.2. Global Blood Plasma Products by: Components (Volume)
        • 7.3.2.1. Immunoglobulin
        • 7.3.2.2. Albumin
        • 7.3.2.3. Hyperimmune Globulin
        • 7.3.2.4. Coagulation
        • 7.3.2.5. Other Plasma Fractionation Products
      • 7.3.3. Global Blood Plasma Products by: Mode of Delivery (Volume)
        • 7.3.3.1. Infusion Solutions
        • 7.3.3.2. Gels
        • 7.3.3.3. Sprays
        • 7.3.3.4. Biomedical Sealants
      • 7.3.4. Global Blood Plasma Products Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Blood Plasma Products (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Plasma Products: by Application(USD Million)
  • Table 2. Blood Plasma Products Immunology , by Region USD Million (2018-2023)
  • Table 3. Blood Plasma Products Oncology , by Region USD Million (2018-2023)
  • Table 4. Blood Plasma Products Pulmonology , by Region USD Million (2018-2023)
  • Table 5. Blood Plasma Products Rheumatology , by Region USD Million (2018-2023)
  • Table 6. Blood Plasma Products Transplant , by Region USD Million (2018-2023)
  • Table 7. Blood Plasma Products Neurology , by Region USD Million (2018-2023)
  • Table 8. Blood Plasma Products Hematology , by Region USD Million (2018-2023)
  • Table 9. Blood Plasma Products: by Components(USD Million)
  • Table 10. Blood Plasma Products Immunoglobulin , by Region USD Million (2018-2023)
  • Table 11. Blood Plasma Products Albumin , by Region USD Million (2018-2023)
  • Table 12. Blood Plasma Products Hyperimmune Globulin , by Region USD Million (2018-2023)
  • Table 13. Blood Plasma Products Coagulation , by Region USD Million (2018-2023)
  • Table 14. Blood Plasma Products Other Plasma Fractionation Products , by Region USD Million (2018-2023)
  • Table 15. Blood Plasma Products: by Mode of Delivery(USD Million)
  • Table 16. Blood Plasma Products Infusion Solutions , by Region USD Million (2018-2023)
  • Table 17. Blood Plasma Products Gels , by Region USD Million (2018-2023)
  • Table 18. Blood Plasma Products Sprays , by Region USD Million (2018-2023)
  • Table 19. Blood Plasma Products Biomedical Sealants , by Region USD Million (2018-2023)
  • Table 20. South America Blood Plasma Products, by Country USD Million (2018-2023)
  • Table 21. South America Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 22. South America Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 23. South America Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 24. Brazil Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 25. Brazil Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 26. Brazil Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 27. Argentina Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 28. Argentina Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 29. Argentina Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 30. Rest of South America Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 31. Rest of South America Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 32. Rest of South America Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 33. Asia Pacific Blood Plasma Products, by Country USD Million (2018-2023)
  • Table 34. Asia Pacific Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 35. Asia Pacific Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 36. Asia Pacific Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 37. China Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 38. China Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 39. China Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 40. Japan Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 41. Japan Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 42. Japan Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 43. India Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 44. India Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 45. India Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 46. South Korea Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 47. South Korea Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 48. South Korea Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 49. Taiwan Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 50. Taiwan Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 51. Taiwan Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 52. Australia Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 53. Australia Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 54. Australia Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 55. Rest of Asia-Pacific Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 56. Rest of Asia-Pacific Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 57. Rest of Asia-Pacific Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 58. Europe Blood Plasma Products, by Country USD Million (2018-2023)
  • Table 59. Europe Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 60. Europe Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 61. Europe Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 62. Germany Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 63. Germany Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 64. Germany Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 65. France Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 66. France Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 67. France Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 68. Italy Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 69. Italy Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 70. Italy Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 71. United Kingdom Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 72. United Kingdom Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 73. United Kingdom Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 74. Netherlands Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 75. Netherlands Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 76. Netherlands Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 77. Rest of Europe Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 78. Rest of Europe Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 79. Rest of Europe Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 80. MEA Blood Plasma Products, by Country USD Million (2018-2023)
  • Table 81. MEA Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 82. MEA Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 83. MEA Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 84. Middle East Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 85. Middle East Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 86. Middle East Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 87. Africa Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 88. Africa Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 89. Africa Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 90. North America Blood Plasma Products, by Country USD Million (2018-2023)
  • Table 91. North America Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 92. North America Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 93. North America Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 94. United States Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 95. United States Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 96. United States Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 97. Canada Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 98. Canada Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 99. Canada Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 100. Mexico Blood Plasma Products, by Application USD Million (2018-2023)
  • Table 101. Mexico Blood Plasma Products, by Components USD Million (2018-2023)
  • Table 102. Mexico Blood Plasma Products, by Mode of Delivery USD Million (2018-2023)
  • Table 103. Blood Plasma Products Sales: by Application(Gallons)
  • Table 104. Blood Plasma Products Sales Immunology , by Region Gallons (2018-2023)
  • Table 105. Blood Plasma Products Sales Oncology , by Region Gallons (2018-2023)
  • Table 106. Blood Plasma Products Sales Pulmonology , by Region Gallons (2018-2023)
  • Table 107. Blood Plasma Products Sales Rheumatology , by Region Gallons (2018-2023)
  • Table 108. Blood Plasma Products Sales Transplant , by Region Gallons (2018-2023)
  • Table 109. Blood Plasma Products Sales Neurology , by Region Gallons (2018-2023)
  • Table 110. Blood Plasma Products Sales Hematology , by Region Gallons (2018-2023)
  • Table 111. Blood Plasma Products Sales: by Components(Gallons)
  • Table 112. Blood Plasma Products Sales Immunoglobulin , by Region Gallons (2018-2023)
  • Table 113. Blood Plasma Products Sales Albumin , by Region Gallons (2018-2023)
  • Table 114. Blood Plasma Products Sales Hyperimmune Globulin , by Region Gallons (2018-2023)
  • Table 115. Blood Plasma Products Sales Coagulation , by Region Gallons (2018-2023)
  • Table 116. Blood Plasma Products Sales Other Plasma Fractionation Products , by Region Gallons (2018-2023)
  • Table 117. Blood Plasma Products Sales: by Mode of Delivery(Gallons)
  • Table 118. Blood Plasma Products Sales Infusion Solutions , by Region Gallons (2018-2023)
  • Table 119. Blood Plasma Products Sales Gels , by Region Gallons (2018-2023)
  • Table 120. Blood Plasma Products Sales Sprays , by Region Gallons (2018-2023)
  • Table 121. Blood Plasma Products Sales Biomedical Sealants , by Region Gallons (2018-2023)
  • Table 122. South America Blood Plasma Products Sales, by Country Gallons (2018-2023)
  • Table 123. South America Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 124. South America Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 125. South America Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 126. Brazil Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 127. Brazil Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 128. Brazil Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 129. Argentina Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 130. Argentina Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 131. Argentina Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 132. Rest of South America Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 133. Rest of South America Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 134. Rest of South America Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 135. Asia Pacific Blood Plasma Products Sales, by Country Gallons (2018-2023)
  • Table 136. Asia Pacific Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 137. Asia Pacific Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 138. Asia Pacific Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 139. China Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 140. China Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 141. China Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 142. Japan Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 143. Japan Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 144. Japan Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 145. India Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 146. India Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 147. India Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 148. South Korea Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 149. South Korea Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 150. South Korea Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 151. Taiwan Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 152. Taiwan Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 153. Taiwan Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 154. Australia Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 155. Australia Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 156. Australia Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 157. Rest of Asia-Pacific Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 158. Rest of Asia-Pacific Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 159. Rest of Asia-Pacific Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 160. Europe Blood Plasma Products Sales, by Country Gallons (2018-2023)
  • Table 161. Europe Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 162. Europe Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 163. Europe Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 164. Germany Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 165. Germany Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 166. Germany Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 167. France Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 168. France Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 169. France Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 170. Italy Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 171. Italy Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 172. Italy Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 173. United Kingdom Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 174. United Kingdom Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 175. United Kingdom Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 176. Netherlands Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 177. Netherlands Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 178. Netherlands Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 179. Rest of Europe Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 180. Rest of Europe Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 181. Rest of Europe Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 182. MEA Blood Plasma Products Sales, by Country Gallons (2018-2023)
  • Table 183. MEA Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 184. MEA Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 185. MEA Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 186. Middle East Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 187. Middle East Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 188. Middle East Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 189. Africa Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 190. Africa Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 191. Africa Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 192. North America Blood Plasma Products Sales, by Country Gallons (2018-2023)
  • Table 193. North America Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 194. North America Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 195. North America Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 196. United States Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 197. United States Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 198. United States Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 199. Canada Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 200. Canada Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 201. Canada Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 202. Mexico Blood Plasma Products Sales, by Application Gallons (2018-2023)
  • Table 203. Mexico Blood Plasma Products Sales, by Components Gallons (2018-2023)
  • Table 204. Mexico Blood Plasma Products Sales, by Mode of Delivery Gallons (2018-2023)
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Company Basic Information, Sales Area and Its Competitors
  • Table 215. Blood Plasma Products: by Application(USD Million)
  • Table 216. Blood Plasma Products Immunology , by Region USD Million (2025-2030)
  • Table 217. Blood Plasma Products Oncology , by Region USD Million (2025-2030)
  • Table 218. Blood Plasma Products Pulmonology , by Region USD Million (2025-2030)
  • Table 219. Blood Plasma Products Rheumatology , by Region USD Million (2025-2030)
  • Table 220. Blood Plasma Products Transplant , by Region USD Million (2025-2030)
  • Table 221. Blood Plasma Products Neurology , by Region USD Million (2025-2030)
  • Table 222. Blood Plasma Products Hematology , by Region USD Million (2025-2030)
  • Table 223. Blood Plasma Products: by Components(USD Million)
  • Table 224. Blood Plasma Products Immunoglobulin , by Region USD Million (2025-2030)
  • Table 225. Blood Plasma Products Albumin , by Region USD Million (2025-2030)
  • Table 226. Blood Plasma Products Hyperimmune Globulin , by Region USD Million (2025-2030)
  • Table 227. Blood Plasma Products Coagulation , by Region USD Million (2025-2030)
  • Table 228. Blood Plasma Products Other Plasma Fractionation Products , by Region USD Million (2025-2030)
  • Table 229. Blood Plasma Products: by Mode of Delivery(USD Million)
  • Table 230. Blood Plasma Products Infusion Solutions , by Region USD Million (2025-2030)
  • Table 231. Blood Plasma Products Gels , by Region USD Million (2025-2030)
  • Table 232. Blood Plasma Products Sprays , by Region USD Million (2025-2030)
  • Table 233. Blood Plasma Products Biomedical Sealants , by Region USD Million (2025-2030)
  • Table 234. South America Blood Plasma Products, by Country USD Million (2025-2030)
  • Table 235. South America Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 236. South America Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 237. South America Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 238. Brazil Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 239. Brazil Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 240. Brazil Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 241. Argentina Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 242. Argentina Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 243. Argentina Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 244. Rest of South America Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 245. Rest of South America Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 246. Rest of South America Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 247. Asia Pacific Blood Plasma Products, by Country USD Million (2025-2030)
  • Table 248. Asia Pacific Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 249. Asia Pacific Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 250. Asia Pacific Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 251. China Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 252. China Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 253. China Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 254. Japan Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 255. Japan Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 256. Japan Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 257. India Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 258. India Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 259. India Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 260. South Korea Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 261. South Korea Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 262. South Korea Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 263. Taiwan Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 264. Taiwan Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 265. Taiwan Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 266. Australia Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 267. Australia Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 268. Australia Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 269. Rest of Asia-Pacific Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 270. Rest of Asia-Pacific Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 271. Rest of Asia-Pacific Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 272. Europe Blood Plasma Products, by Country USD Million (2025-2030)
  • Table 273. Europe Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 274. Europe Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 275. Europe Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 276. Germany Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 277. Germany Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 278. Germany Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 279. France Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 280. France Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 281. France Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 282. Italy Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 283. Italy Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 284. Italy Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 285. United Kingdom Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 286. United Kingdom Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 287. United Kingdom Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 288. Netherlands Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 289. Netherlands Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 290. Netherlands Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 291. Rest of Europe Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 292. Rest of Europe Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 293. Rest of Europe Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 294. MEA Blood Plasma Products, by Country USD Million (2025-2030)
  • Table 295. MEA Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 296. MEA Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 297. MEA Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 298. Middle East Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 299. Middle East Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 300. Middle East Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 301. Africa Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 302. Africa Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 303. Africa Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 304. North America Blood Plasma Products, by Country USD Million (2025-2030)
  • Table 305. North America Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 306. North America Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 307. North America Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 308. United States Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 309. United States Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 310. United States Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 311. Canada Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 312. Canada Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 313. Canada Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 314. Mexico Blood Plasma Products, by Application USD Million (2025-2030)
  • Table 315. Mexico Blood Plasma Products, by Components USD Million (2025-2030)
  • Table 316. Mexico Blood Plasma Products, by Mode of Delivery USD Million (2025-2030)
  • Table 317. Blood Plasma Products Sales: by Application(Gallons)
  • Table 318. Blood Plasma Products Sales Immunology , by Region Gallons (2025-2030)
  • Table 319. Blood Plasma Products Sales Oncology , by Region Gallons (2025-2030)
  • Table 320. Blood Plasma Products Sales Pulmonology , by Region Gallons (2025-2030)
  • Table 321. Blood Plasma Products Sales Rheumatology , by Region Gallons (2025-2030)
  • Table 322. Blood Plasma Products Sales Transplant , by Region Gallons (2025-2030)
  • Table 323. Blood Plasma Products Sales Neurology , by Region Gallons (2025-2030)
  • Table 324. Blood Plasma Products Sales Hematology , by Region Gallons (2025-2030)
  • Table 325. Blood Plasma Products Sales: by Components(Gallons)
  • Table 326. Blood Plasma Products Sales Immunoglobulin , by Region Gallons (2025-2030)
  • Table 327. Blood Plasma Products Sales Albumin , by Region Gallons (2025-2030)
  • Table 328. Blood Plasma Products Sales Hyperimmune Globulin , by Region Gallons (2025-2030)
  • Table 329. Blood Plasma Products Sales Coagulation , by Region Gallons (2025-2030)
  • Table 330. Blood Plasma Products Sales Other Plasma Fractionation Products , by Region Gallons (2025-2030)
  • Table 331. Blood Plasma Products Sales: by Mode of Delivery(Gallons)
  • Table 332. Blood Plasma Products Sales Infusion Solutions , by Region Gallons (2025-2030)
  • Table 333. Blood Plasma Products Sales Gels , by Region Gallons (2025-2030)
  • Table 334. Blood Plasma Products Sales Sprays , by Region Gallons (2025-2030)
  • Table 335. Blood Plasma Products Sales Biomedical Sealants , by Region Gallons (2025-2030)
  • Table 336. South America Blood Plasma Products Sales, by Country Gallons (2025-2030)
  • Table 337. South America Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 338. South America Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 339. South America Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 340. Brazil Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 341. Brazil Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 342. Brazil Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 343. Argentina Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 344. Argentina Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 345. Argentina Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 346. Rest of South America Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 347. Rest of South America Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 348. Rest of South America Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 349. Asia Pacific Blood Plasma Products Sales, by Country Gallons (2025-2030)
  • Table 350. Asia Pacific Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 351. Asia Pacific Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 352. Asia Pacific Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 353. China Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 354. China Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 355. China Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 356. Japan Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 357. Japan Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 358. Japan Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 359. India Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 360. India Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 361. India Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 362. South Korea Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 363. South Korea Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 364. South Korea Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 365. Taiwan Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 366. Taiwan Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 367. Taiwan Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 368. Australia Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 369. Australia Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 370. Australia Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 371. Rest of Asia-Pacific Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 372. Rest of Asia-Pacific Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 373. Rest of Asia-Pacific Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 374. Europe Blood Plasma Products Sales, by Country Gallons (2025-2030)
  • Table 375. Europe Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 376. Europe Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 377. Europe Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 378. Germany Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 379. Germany Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 380. Germany Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 381. France Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 382. France Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 383. France Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 384. Italy Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 385. Italy Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 386. Italy Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 387. United Kingdom Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 388. United Kingdom Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 389. United Kingdom Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 390. Netherlands Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 391. Netherlands Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 392. Netherlands Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 393. Rest of Europe Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 394. Rest of Europe Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 395. Rest of Europe Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 396. MEA Blood Plasma Products Sales, by Country Gallons (2025-2030)
  • Table 397. MEA Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 398. MEA Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 399. MEA Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 400. Middle East Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 401. Middle East Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 402. Middle East Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 403. Africa Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 404. Africa Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 405. Africa Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 406. North America Blood Plasma Products Sales, by Country Gallons (2025-2030)
  • Table 407. North America Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 408. North America Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 409. North America Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 410. United States Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 411. United States Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 412. United States Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 413. Canada Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 414. Canada Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 415. Canada Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 416. Mexico Blood Plasma Products Sales, by Application Gallons (2025-2030)
  • Table 417. Mexico Blood Plasma Products Sales, by Components Gallons (2025-2030)
  • Table 418. Mexico Blood Plasma Products Sales, by Mode of Delivery Gallons (2025-2030)
  • Table 419. Research Programs/Design for This Report
  • Table 420. Key Data Information from Secondary Sources
  • Table 421. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Plasma Products: by Application USD Million (2018-2023)
  • Figure 5. Global Blood Plasma Products: by Components USD Million (2018-2023)
  • Figure 6. Global Blood Plasma Products: by Mode of Delivery USD Million (2018-2023)
  • Figure 7. South America Blood Plasma Products Share (%), by Country
  • Figure 8. Asia Pacific Blood Plasma Products Share (%), by Country
  • Figure 9. Europe Blood Plasma Products Share (%), by Country
  • Figure 10. MEA Blood Plasma Products Share (%), by Country
  • Figure 11. North America Blood Plasma Products Share (%), by Country
  • Figure 12. Global Blood Plasma Products: by Application Gallons (2018-2023)
  • Figure 13. Global Blood Plasma Products: by Components Gallons (2018-2023)
  • Figure 14. Global Blood Plasma Products: by Mode of Delivery Gallons (2018-2023)
  • Figure 15. South America Blood Plasma Products Share (%), by Country
  • Figure 16. Asia Pacific Blood Plasma Products Share (%), by Country
  • Figure 17. Europe Blood Plasma Products Share (%), by Country
  • Figure 18. MEA Blood Plasma Products Share (%), by Country
  • Figure 19. North America Blood Plasma Products Share (%), by Country
  • Figure 20. Global Blood Plasma Products share by Players 2023 (%)
  • Figure 21. Global Blood Plasma Products share by Players (Top 3) 2023(%)
  • Figure 22. Global Blood Plasma Products share by Players (Top 5) 2023(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. ADMA Biologics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. ADMA Biologics, Inc. (United States) Revenue: by Geography 2023
  • Figure 26. Cerus Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Cerus Corporation (United States) Revenue: by Geography 2023
  • Figure 28. China Biologic Products, Inc. (China) Revenue, Net Income and Gross profit
  • Figure 29. China Biologic Products, Inc. (China) Revenue: by Geography 2023
  • Figure 30. CSL Limited (Australia) Revenue, Net Income and Gross profit
  • Figure 31. CSL Limited (Australia) Revenue: by Geography 2023
  • Figure 32. Biotest (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Biotest (Germany) Revenue: by Geography 2023
  • Figure 34. Intas Pharmaceuticals Limited (India) Revenue, Net Income and Gross profit
  • Figure 35. Intas Pharmaceuticals Limited (India) Revenue: by Geography 2023
  • Figure 36. Kedrion (Italy) Revenue, Net Income and Gross profit
  • Figure 37. Kedrion (Italy) Revenue: by Geography 2023
  • Figure 38. LFB S.A. (France) Revenue, Net Income and Gross profit
  • Figure 39. LFB S.A. (France) Revenue: by Geography 2023
  • Figure 40. Octapharma AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 41. Octapharma AG (Switzerland) Revenue: by Geography 2023
  • Figure 42. PrIME Biologics Pte Ltd. (Singapore) Revenue, Net Income and Gross profit
  • Figure 43. PrIME Biologics Pte Ltd. (Singapore) Revenue: by Geography 2023
  • Figure 44. Global Blood Plasma Products: by Application USD Million (2025-2030)
  • Figure 45. Global Blood Plasma Products: by Components USD Million (2025-2030)
  • Figure 46. Global Blood Plasma Products: by Mode of Delivery USD Million (2025-2030)
  • Figure 47. South America Blood Plasma Products Share (%), by Country
  • Figure 48. Asia Pacific Blood Plasma Products Share (%), by Country
  • Figure 49. Europe Blood Plasma Products Share (%), by Country
  • Figure 50. MEA Blood Plasma Products Share (%), by Country
  • Figure 51. North America Blood Plasma Products Share (%), by Country
  • Figure 52. Global Blood Plasma Products: by Application Gallons (2025-2030)
  • Figure 53. Global Blood Plasma Products: by Components Gallons (2025-2030)
  • Figure 54. Global Blood Plasma Products: by Mode of Delivery Gallons (2025-2030)
  • Figure 55. South America Blood Plasma Products Share (%), by Country
  • Figure 56. Asia Pacific Blood Plasma Products Share (%), by Country
  • Figure 57. Europe Blood Plasma Products Share (%), by Country
  • Figure 58. MEA Blood Plasma Products Share (%), by Country
  • Figure 59. North America Blood Plasma Products Share (%), by Country
List of companies from research coverage that are profiled in the study
  • ADMA Biologics, Inc. (United States)
  • Cerus Corporation (United States)
  • China Biologic Products, Inc. (China)
  • CSL Limited (Australia)
  • Biotest (Germany)
  • Intas Pharmaceuticals Limited (India)
  • Kedrion (Italy)
  • LFB S.A. (France)
  • Octapharma AG (Switzerland)
  • PrIME Biologics Pte Ltd. (Singapore)
Additional players considered in the study are as follows:
Shanghai RAAS Blood Products Co., Ltd (China) , Sanquin (Netherlands) , Others
Select User Access Type

Key Highlights of Report


Apr 2024 219 Pages 62 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Blood Plasma Products Quantitative research analysis
Global Blood Plasma Products Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as ADMA Biologics, Inc. (United States), Cerus Corporation (United States), China Biologic Products, Inc. (China), CSL Limited (Australia), Biotest (Germany), Intas Pharmaceuticals Limited (India), Kedrion (Italy), LFB S.A. (France), Octapharma AG (Switzerland) and PrIME Biologics Pte Ltd. (Singapore) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Awareness about Blood and Plasma Donation " is seen as one of major influencing trends for Blood Plasma Products Market during projected period 2023-2030.
The Blood Plasma Products market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Blood Plasma Products Report?

Have a Query? Click Here

Other Related Reports

Herbal Supplements Comprehensive Study by Type (Moringa, Echinacea, Flaxseeds, Turmeric, Ginger, Ginseng), Application (Pharmaceuticals, Food And Drink, Personal Care Products, Other), Distribution C...
$ 3650
Water Bed Comprehensive Study by Type (Hard Edge Water Bed, Soft Edge Water Bed), Distribution Channel (Online, Offline), Mattress (Free Flow Mattress, Semi-Wave less Mattress, Wave less Mattress), S...
$ 3450
Conductive Gloves Comprehensive Study by Industry (Petrochemical, Cleanrooms, Paint, Electronics, Pharmaceutical, Other), Size (Small, Medium, Large, Extra Large), Sales Channel (Online, Offline), Ma...
$ 3450
Animal Antibiotics and Antimicrobials Comprehensive Study by Type (Etracyclines, Penicillins, Macrolides, Aminoglycosides, Sulfonamides, Fluoroquinolones, Lincosamides, Cephalosporins, Other ), Appli...
$ 3650
Medical Elastomers Comprehensive Study by Type (Thermoset Elastomers, Thermoplastic Elastomers), Application (Medical Tubes, Catheters, Gloves, Syringes, Medical Bags, Others), End-Users (Medical Dev...
$ 3350
Travelers Vaccines Comprehensive Study by Type (Mono Vaccines, Combination Vaccines), Application (Tourists, Students, Workers, Others), Disease (Meningococcal Vaccine, Japanese Encephalitis Vaccine,...
$ 3450